Effect of Fatigue on Health-Related Quality of Life and Work Productivity in Psoriatic Arthritis: Findings From a Real-World Survey

Abstract

Objective To evaluate fatigue frequency and severity among patients with psoriatic arthritis (PsA) and assess the impact of fatigue severity on patient-reported outcome measures (PROMs) assessing quality of life, function, and work productivity. Methods Data were derived from the Adelphi Disease Specific Programme, a cross-sectional survey conducted in 2018 in the United States and Europe. Patients had physician-confirmed PsA. Fatigue was collected as a binary variable and through its severity (0-10 scale, using the Psoriatic Arthritis Impact of Disease (PsAID) fatigue question) from patients; physicians also reported patient fatigue (yes/no). Other PROMs included EQ-5D-5L for health-related quality of life (HRQoL), Health Assessment Questionnaire-Disability Index (HAQ-DI), and Work Productivity and Activity Impairment (WPAI). Multivariate linear regression was used to evaluate the association between fatigue severity and other PROMs. Results Among the 831 included patients (mean age 47.5 years, mean disease duration 5.3 years, 46.9% female, 48.1% receiving a biologic), fatigue was reported by 78.3% of patients. Patients with greater fatigue severity had greater disease duration, PsA severity, pain levels, body surface area affected by psoriasis, and swollen and tender joint counts (all p<0.05). In multivariate analyses, patients with greater fatigue severity experienced worse physical functioning, HRQoL, and work productivity (all p<0.001). Presence of fatigue was under-reported by physicians (reported in only 32.0% of patients who self-reported fatigue). Conclusion Prevalence of patient-reported fatigue was high among PsA patients and under-recognized by physicians. Fatigue severity was associated with altered physical functioning, work productivity, and HRQoL.

Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

“…We additionally observed that both dosing regimens of IXE were effective in reducing fatigue in patients across psoriasis severity groups, compared to treatment with PBO, over 24 weeks. Reducing fatigue among the patient population under study has the potential to improve patient well-being and daily function, which may encourage greater compliance with prescribed treatment regimens, fostering better long-term health outcomes [ 36 ].…”

“It’s Like Listening to the Radio with a Little Interference”: A Qualitative Study Describing Pain Management among Patients with Psoriatic Arthritis

“…Assessment of disease activity was not collected since a widely accepted index for measuring disease activity in PsA is lacking [39]. Further, experiences of pain are not exclusively correlated to disease activity but are also related to factors such as fatigue [40], and activity limitations [41], data on which were collected. Our sample included only a few men, which might not mirror the population.…”

Fatigue in Inflammatory Joint Diseases

“…In another study, it was shown that fatigue severity was associated with poorer health status, physical functioning, work productivity, and health-related life quality. Patients reporting higher levels of fatigue were older, had higher disease activity and perceived pain levels, had a longer time since diagnosis and symptom duration, and had more frequent anxiety/depressive symptoms [100]. Reduction in disease activity is associated with lower fatigue levels, and decreased fatigue levels were observed in 81.5% of patients with very low disease activity (VLDA).…”